Risk of zoster in patients on immunosuppressant therapy: evaluation of current data

Am J Infect Control. 2015 Apr 1;43(4):420-1. doi: 10.1016/j.ajic.2015.01.003. Epub 2015 Feb 14.

Authors

Silvio S T Tafuri¹, Maria M C Chironna², Michele M Q Quarto², Cinzia C G Germinario²

Affiliations

¹ Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy. Electronic address: silvio.tafuri@uniba.it.
² Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

PMID: 25690878
DOI: 10.1016/j.ajic.2015.01.003

No abstract available

Publication types

Letter

MeSH terms

Female
Herpes Zoster / epidemiology*
Herpes Zoster / prevention & control
Herpesvirus 3, Human
Humans
Immunosuppressive Agents / adverse effects*
Middle Aged
Rheumatic Fever / complications
Rheumatic Fever / drug therapy
Risk Factors
Vaccination

Substances

Immunosuppressive Agents